NCT03317210View on ClinicalTrials.gov

Intravenous Treatment of Anemia in Pregnancy

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 1, 2002

Primary Completion Date

July 31, 2006

Study Completion Date

July 31, 2006

Conditions
Anemia
Interventions
DRUG

iron sucrose (200 mg VENOFER®)

According to hemoglobin level at the start of the therapy, the women were either treated with intravenous iron and rhEPO or with intravenous iron only twice weekly.

DRUG

recombinant human erythropoietin (10,000 U EPREX®)

According to hemoglobin level at the start of the therapy, the women were treated with rhEPO twice weekly.

All Listed Sponsors
lead

University of Zurich

OTHER

NCT03317210 - Intravenous Treatment of Anemia in Pregnancy | Biotech Hunter | Biotech Hunter